Safety and Efficacy of Cangrelor in Acute Coronary Syndromes: A Systematic Review and Network Meta-Analysis.
Mostafa Reda MostafaMohamed Magdi EidAhmed Khaled AwadAndrew TaklaAbdul Rhman HassanBasant E KatameshMajd M AlBarakatAbdul Rhman ZiadaSarah MohamedKarim M Al-AziziAndrew M GoldsweigPublished in: American journal of cardiovascular drugs : drugs, devices, and other interventions (2023)
Cangrelor has comparable outcomes to clopidogrel in patients with acute coronary syndromes and can be used as a reliable alternative in this population.